Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2018, Article ID 6503435, 5 pages
https://doi.org/10.1155/2018/6503435
Case Report

Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation

Department of Cardiology, San Eugenio Hospital, Rome, Italy

Correspondence should be addressed to Francesco Summaria; moc.liamg@airammus.f

Received 5 December 2017; Accepted 14 January 2018; Published 5 March 2018

Academic Editor: Nurten Sayar

Copyright © 2018 Francesco Summaria et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rubboli, M. Colletta, J. Valencia et al., “Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting,” Journal of Interventional Cardiology, vol. 22, no. 4, pp. 390–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. De Luca, S. Leonardi, C. Cavallini et al., “Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: the EYESHOT study,” European Heart Journal: Acute Cardiovascular Care, vol. 4, no. 5, pp. 441–452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Chiarella, E. Santoro, S. Domenicucci, A. Maggioni, and C. Vecchio, “Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study,” American Journal of Cardiology, vol. 81, no. 7, pp. 822–827, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Lanzillo, M. Di Roma, A. Sciahbasi et al., “Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction,” Acute Cardiac Care, vol. 15, no. 1, pp. 11–16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Pizzetti, G. Belotti, A. Margonato et al., “Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size,” European Heart Journal, vol. 17, no. 3, pp. 421–428, 1996. View at Publisher · View at Google Scholar
  6. D. Nayak, W. S. Aronow, R. Sukhija, J. A. McClung, C. E. Monsen, and R. N. Belkin, “Comparison of frequency of left ventricular thrombi in patients with anterior wall versus non-anterior wall acute myocardial infarction treated with antithrombotic and antiplatelet therapy with or without coronary revascularization,” American Journal of Cardiology, vol. 93, no. 12, pp. 1529-1530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Heidbuchel, P. Verhamme, M. Alings et al., “European Heart Rhythm Association, European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation,” Europace Journal, vol. 15, no. 5, pp. 625–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Patel, K. W. Mahaffey, J. Garg et al., “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” New England Journal of Medicine, vol. 365, no. 10, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. T. Ruff, R. P. Giugliano, E. Braunwald et al., “Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials,” The Lancet, vol. 383, no. 9921, pp. 955–962, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Makrides, “Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy,” BMJ Case Reports, vol. 2016, p. bcr2016217843, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Mano, K. Koide, H. Sukegawa, M. Kodaira, and T. Ohki, “Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction,” Heart and Vessels, vol. 31, no. 1, pp. 118–123, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Seecheran, V. Seecheran, S. Persad, and N. A. Seecheran, “Rivaroxaban as an antithrombotic agent in a patient with ST-segment elevation myocardial infarction and left ventricular thrombus: a case report,” Journal of Investigative Medicine High Impact Case Reports, vol. 5, no. 1, p. 2324709617697991, 2017. View at Publisher · View at Google Scholar
  13. C. Hammerstingl, B. Pötzsch, and G. Nickenig, “Resolution of giant left atrial appendage thrombus with rivaroxaban,” Thrombosis and Haemostasis, vol. 109, no. 4, pp. 583-584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Gibson, R. Mehran, C. Bode et al., “Prevention of bleeding in patients with atrial fibrillation undergoing PCI,” New England Journal of Medicine, vol. 375, no. 25, pp. 2423–2434, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. C. P. Cannon, D. L. Bhatt, J. Oldgren et al., “Antithrombotic therapy with dabigatran after PCI in atrial fibrillation,” New England Journal of Medicine, vol. 377, no. 16, pp. 1513–1524, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Y. H. Lip, R. Nieuwlaat, R. Pisters, D. A. Lane, and H. J. G. M. Crijns, “Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation,” Chest, vol. 137, no. 2, pp. 263–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Y. H. Lip, L. Frison, J. L. Halperin, and D. A. Lane, “Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile inr, elderly, drugs/alcohol concomitantly) score,” Journal of the American College of Cardiology, vol. 57, no. 2, pp. 173–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Apostolakis, D. A. Lane, H. Buller, and G. Y. H. Lip, “Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial,” Thrombosis and Haemostasis, vol. 110, no. 5, pp. 1074–1079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Y. H. Lip, S. Windecker, K. Huber et al., “Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS),” European Heart Journal, vol. 35, no. 45, pp. 3155–3179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Roffi, C. Patrono, J.-P. Collet et al., “2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” European Heart Journal, vol. 37, no. 3, pp. 267–315, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. C. P. Cannon, S. Gropper, D. L. Bhatt et al., “Design and rationale of the RE-DUAL PCI trial: a prospective, randomized, phase 3b study comparing the safety and efficacy of dual antithrombotic therapy with dabigatran etexilate versus warfarin triple therapy in patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stenting,” Clinical Cardiology, vol. 39, no. 10, pp. 555–564, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Palmerini, U. Benedetto, G. Biondi-Zoccai et al., “Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis,” Journal of the American College of Cardiology, vol. 65, no. 23, pp. 2496–2507, 2015. View at Publisher · View at Google Scholar · View at Scopus